What Does Dynavax Technologies Do?

Total employees343
HeadquartersEmeryville
Founded

Dynavax Technologies Corporation (NASDAQ: DVAX) is a commercial-stage biopharmaceutical company that develops and commercializes novel vaccines to prevent infectious diseases. The company's flagship product is HEPLISAV-B®, an adult hepatitis B vaccine. Dynavax also leverages its proprietary Toll-like Receptor 9 (TLR9) agonist adjuvant, CpG 1018®, to enhance the immune response to vaccine antigens, which is used in HEPLISAV-B and is being evaluated in other vaccine development programs, including collaborations for COVID-19 and pertussis vaccines. Their focus is on addressing unmet medical needs in infectious diseases through innovative vaccine technology.

Where Is Dynavax Technologies's Headquarters?

Dynavax Technologies officeDynavax Technologies officeDynavax Technologies officeDynavax Technologies office
*Images sourced via web search. Rights belong to original owners

HQ Function

The Emeryville headquarters serves as the central hub for Dynavax's corporate leadership, strategic planning, research and development oversight, commercial operations, finance, and administrative functions.

Notable Features:

Located in a modern office building, the headquarters likely features contemporary office spaces designed for collaboration and may include specialized laboratory facilities or access to nearby research infrastructure, reflecting its biopharmaceutical focus.

Work Culture:

The work culture at Dynavax's headquarters is likely dynamic, mission-driven, and scientifically focused, emphasizing innovation, collaboration, and a commitment to public health. Employees often share a passion for developing impactful vaccines.

HQ Significance:

Its location in the San Francisco Bay Area provides strategic advantages, including access to a rich talent pool, leading research institutions, venture capital, and a vibrant ecosystem of biotech companies and collaborators.

Values Reflected in HQ: The headquarters' operations and environment likely reflect Dynavax's core values such as scientific excellence, innovation, integrity, patient focus, and a commitment to making a difference in global health.

Location:

Dynavax Technologies has a focused global presence, primarily centered in North America and Europe. Its U.S. operations drive research, development, and commercialization, while its European office in Germany supports market access and commercial activities in the region. Furthermore, its CpG 1018 adjuvant is supplied globally to partners for use in various vaccine development programs, extending its impact worldwide. The company also engages in global clinical trials and collaborations to advance its pipeline.

Street Address:

2100 Powell Street, Suite 700

City:

Emeryville

State/Province:

California

Country:

USA

Where Else Does Dynavax Technologies Operate Around the World?

DĂĽsseldorf, Germany

Address: Graf-Adolf-Platz 15, 40213 DĂĽsseldorf, Germany

Serves as a key base for engaging with European healthcare systems, regulatory authorities, and distribution partners to expand the reach of Dynavax's vaccines in the region.

Buying Intent Signals for Dynavax Technologies

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Dynavax Technologies? Meet the Executive Team

As of April 2025, Dynavax Technologies' leadership includes:

Ryan Spencer - Chief Executive Officer
Donn Casale - Chief Commercial Officer
Kelly MacDonald - Chief Financial Officer
Robert Janssen, M.D. - Chief Medical Officer, Head of Research and Development
Justin Burgess - Chief Operating Officer
Julie Eastland - Chief Business Officer
Rita O'Connor - Senior Vice President, Technical Operations

Who's Investing in Dynavax Technologies?

Dynavax Technologies has been backed by several prominent investors over the years, including:

BlackRock Inc.
The Vanguard Group, Inc.
State Street Corporation
Bain Capital Life Sciences
RA Capital Management
Perceptive Advisors LLC
Point72 Asset Management, L.P.

What Leadership Changes Has Dynavax Technologies Seen Recently?

Hire1
Exits1

Over the past 12-18 months, Dynavax Technologies has seen some key leadership transitions aimed at strengthening its commercial and operational capabilities. Notably, there was a transition in the Chief Operating Officer role and additions to the board. Overall, the core executive team has shown stability.

Departures

David Novack, David Novack transitioned from his role as SVP, Operations to an advisory capacity with the company.

New Appointments:

Justin Burgess, Justin Burgess appointed as Chief Operating Officer to lead manufacturing and operational functions.

What Technology (Tech Stack) Is Used byDynavax Technologies?

Discover the tools Dynavax Technologies uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Dynavax Technologies Email Formats and Examples

Dynavax Technologies commonly uses the email format [first_initial][last]@dynavax.com. This is a standard convention for many companies in the biopharmaceutical industry.

[first_initial][last]@dynavax.com

Format

rspencer@dynavax.com

Example

90%

Success rate

What's the Latest News About Dynavax Technologies?

GlobeNewswire • May 7, 2024

Dynavax Technologies news title: Dynavax Reports First Quarter 2024 Financial Results

Dynavax announced its financial results for the first quarter of 2024, highlighting HEPLISAV-B net product revenue of $50.7 million, a 17% increase year-over-year. The company reaffirmed its full-year 2024 financial guidance....more

GlobeNewswire • February 21, 2024

Dynavax Technologies news title: Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results

Dynavax reported strong financial results for Q4 and full-year 2023, driven by continued growth of HEPLISAV-B sales. The company also provided updates on its pipeline, including its plague vaccine program in collaboration with the U.S. Department of Defense....more

GlobeNewswire • January 8, 2024

Dynavax Technologies news title: Dynavax Announces Preliminary Full-Year 2023 HEPLISAV-B Net Product Revenue and Provides Full-Year 2024 Financial Guidance

Dynavax announced preliminary HEPLISAV-B net product revenue for full-year 2023, expecting it to be approximately $213 million, and provided its financial guidance for 2024, anticipating continued growth....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Dynavax Technologies, are just a search away.